These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19941790)

  • 1. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza.
    Nishiura H; Iwata K
    Euro Surveill; 2009 Nov; 14(45):. PubMed ID: 19941790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].
    Hara M; Ohfuji S; Fukushima W; Hirota Y
    Nihon Eiseigaku Zasshi; 2013; 68(3):153-60. PubMed ID: 24077487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 4. A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory.
    Loew-Baselli A; Pavlova BG; Fritsch S; Poellabauer EM; Draxler W; Kistner O; Behre U; Angermayr R; Neugebauer J; Kirsten K; Förster-Waldl E; Koellges R; Ehrlich HJ; Barrett PN
    Vaccine; 2012 Sep; 30(41):5956-66. PubMed ID: 22846396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
    Shim E; Meyers LA; Galvani AP
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
    Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
    N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
    Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
    Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
    Hara M; Hanaoka T; Mizushima T; Honma J; Maeda K; Ohfuji S; Tanaka K; Hirota Y
    Vaccine; 2011 Oct; 29(46):8323-9. PubMed ID: 21893146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swine flu outbreak. China first to vaccinate against novel H1N1 virus.
    Stone R
    Science; 2009 Sep; 325(5947):1482-3. PubMed ID: 19762610
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients.
    Giannattasio A; Mariano M; Romano R; Chiatto F; Liguoro I; Borgia G; Guarino A; Lo Vecchio A
    BMC Infect Dis; 2015 Aug; 15():329. PubMed ID: 26265328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).
    Hanquet G; Van Damme P; Brasseur D; De Cuyper X; Gregor S; Holmberg M; Martin R; Molnár Z; Pompa MG; Snacken R; van der Sande M; Van Ranst M; Wirtz A; Neels P
    Vaccine; 2011 Jan; 29(3):370-7. PubMed ID: 21075164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.
    Riley S; Wu JT; Leung GM
    PLoS Med; 2007 Jun; 4(6):e218. PubMed ID: 17579511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vaccination strategies during pandemic outbreaks.
    Bowman CS; Arino J; Moghadas SM
    Math Biosci Eng; 2011 Jan; 8(1):113-22. PubMed ID: 21361403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.